Welcoming Márton A. Simon PhD in our Team
Welcoming Irena Adkins to our Team
Zalán Péterfi Discusses the Future of Migraine Therapy in Világgazdaság
CREATe Tx Achieves In Vivo Proof-of-Concept for Small Molecule-Controlled Gene Therapy Platform
CREATe Therapeutics Takes the Stage at Cell & Gene Therapy International 2025 in Boston
VRG Presenting at Re:Biotech Hungary
CREATe Therapeutics Showcases Drug-Controlled Gene Therapy Platform at CGTI EU
New International Collaboration: VRG Therapeutics Awarded Grant for Biased Drug Discovery Research
Novamigra Therapeutics Secures ~€3 Million Funding to Advance First-in-Human Study of Migraine Prophylaxis Asset VRG-145
We have made it to the AlbionVC Healthtech Market Map 2025
New member to the team: Bence Csapó
We’re excited to share a recent interview with Zalán Péterfi, Co-Founder and Chairman of the Board of Novamigra, featured in Világgazdaság!
Welcoming Dr. Natalia Novac to VRG Therapeutics!
New member to the team: Antal Szenes-Nagy
VRG Therapeutics' project selected as a winner of the "Fast Track" grant by NRDIO - National Research Development and Innovation Office (NKFIH)
VRG Therapeutics is expanding into the Netherlands!
VRG Therapeutics has been selected among the "Early Stage Startups to Watch" in the drug discovery space by Sifted!
New VRG Tx patent application filed!
VRG Therapeutics among the top 30 startups to participate in the Labena Ventures Accelerator Program!
Publication - Journal of Biological Chemistry
Publication - Chemogenetic Inhibition of the Lateral Hypothalamus Effectively Reduces Food Intake in Rats in a Translational Proof-of-Concept Study
First stage gating meeting of the year
New member to the team: Tamás Csikai
New member to the team: Gábor Oroszlán, PhD
New member to the team: Ambrus Gordos, PharmD
Meet in Italy for Life Sciences - Startup Breeding 2023
New member to the team: Lili Kovanecz-Jármi
New member to the team: Dr. Judit Matúz
International Biotech Days 2023
Bio Europe 2023 - Startup Spotlight
BIO-Europe 2023 Startup Spotlight
Meet in Italy for Life Sciences - Awards
Meet in Italy - Meet the startup: Vrg Therapeutics
INNLIFES interview - VRG Therapeutics is the most innovative proposal of MIT4LS 2023
Recognition of our student researcher
MBH Bank's Macronome Macroverse conference
Milestone Alert: VRG Tx Launches Its In Vivo R&D Facility!
New member to the team: Ildikó Dósa
Publication - Journal of Biological Chemistry
VRG Therapeutics Advances VRG-145, a Synergistic Oral Combination for Migraine Prophylaxis, to Final Preclinical Stage
CESAwards: We are regional finalists!
New member to the team: Mariann Kremlitzka, PhD
New member to the team: Dr. Zoltán Urbányi
Press release: Experimental verification of our AI-powered drug discovery
3.JPG)
.JPG)
